"We would encourage you to visit www.coronavirus.gov for the latest information and guidance related to COVID-19"

Speakers

Stanley Plotkin, MD

Consultant and Emeritus Professor, University of Pennsylvania, Vaxconsult, LLP

Paul Offit, MD

Director, Vaccine Education Center, Division of Infectious Diseases, Children's Hospital of Philadelphia.

Presentation Title

William C. Gruber, MD

SVP Vaccine Clinical Research and Development, Pfizer Inc

Presentation Title

John Howard, MS, MBA

President and Founder, Applied Biotechnology Institute, Inc (ABI)

Presentation Title

Drew Weissman, MD, PhD

Professor, Department of Medicine, Director of Vaccine Research, Infectious Diseases Division, Perelman School of Medicine, University of Pennsylvania

Presentation Title

Kayvon Modjarrad, M.D., Ph.D

Director, Emerging Infectious Diseases Branch, Walter Reed Army Institute of Research

Presentation Title

Ruxandra Draghia-Akli, MD, Ph.D

Global Head, Global Public Health R&D, Johnson & Johnson

Presentation Title

David Weiner, M.D., Ph.D.

Executive Vice President, Director, Vaccine & Immunotherapy Center,
The Wistar Institute

Jay A. Berzofsky, M.D., Ph.D.

Chief, Vaccine Branch,
Center for Cancer Research,
National Cancer Institute

Samir N. Khleif, M.D.

Director, Jeannie and Tony Loop Immuno-Oncology Research Laboratory, Lombardi Comprehensive Cancer Center

Alba Grifoni PhD

La Jolla Institute for Immunology

Adrian V.S. Hill MD, Ph.D.

Director, The Jenner Institute, Nuffield Department of Medicine, University of Oxford

Presentation Title

Raches Ella, MBBS, MS

Head - Business Development & Advocacy, Bharat Biotech

Presentation Title

Stephen L. Hoffman, M.D.

Chief Executive and Scientific Officer
Sanaria Inc.

Nikolai Petrovsky, MBBS, Ph.D

Flinders University, Australia, Research Director, Vaxine Pty Ltd

Presentation Title
thumb-image

Karen A. Norris, Ph.D.

Professor, Georgia Research Alliance Eminent Scholar, Charles H. Wheatley Chair in Immunology and Translational Biomedical Research, Center for Vaccines and Immunology, Department of Infectious Diseases, College of Veterinary Medicine, University of Georgia

Presentation Title

Ralph S. Baric, Ph.D.

University of North Carolina Kenan Distinguished Professor, Epidemiology, Gillings School of Global Public Health and Microbiology and Immunology, School of Medicine.

Presentation Title

Peter Marks, MD, PhD

Director, Center for Biologics Evaluation and Research, FDA

Paolo Lusso, M.D., Ph.D

Chief, Viral Pathogenesis, Laboratory of Immunoregulation, NIAID/NIH,

Andrew Lees, Ph.D.

CEO/CSO, Fina Biosolutions

Yongjun Sui, Ph.D.

Associate Scientist, Vaccine Branch, Center for Cancer Research, National Cancer Institute

Joost Oppenheim, M.D.

Senior Investigator, Head Cellular Immunology Section, Center for Cancer Research, National Cancer Institute

Mark J. Newman, Ph.D.

Chief Scientific Officer, GeoVax Inc

Presentation Title

Thomas Tillett, Ph.D.

CEO, MBF Therapeutics

Sean M. Sullivan, Ph.D.

Executive Director, Process Science & Technology, Arcturus Therapeutics, Inc.

Alexander Bukreyev, Ph.D.

Professor, Co-Principal Investigator Molecular Mechanisms of the Dysregulated Immune Response to Ebola Virus, Departments of Pathology and Microbiology & Immunology, University of Texas Medical Branch

Presentation Title

Louis D. Falo, Jr., M.D., Ph.D.

Chairman, Department of Dermatology, University of Pittsburgh School of Medicine

Kenneth D. Stuart, Ph.D.

Professor, University of Washington School of Medicine, Department of Pediatrics and Seattle Children’s Research Institute, Center for Global Infectious Disease Research (CGIDR)

Presentation Title

James E. Crowe, Jr., M.D.

Director, Vanderbilt Vaccine Center

Presentation Title

Dan Barouch, M.D., Ph.D

William Bosworth Castle Professor of Medicine, Harvard Medical School, Director, Center for Virology and Vaccine Research, BIDMC

Daniela Weiskopf, M.D., Ph.D

Research Assistant Professor, La Jolla Institute for Immunology

Presentation Title

Kwong Tsang, Ph.D

CSO, Precision Biologics, Inc

Presentation Title

Kevin O. Saunders, Ph.D

Associate Professor, Department of Surgery, Director, Laboratory of Protein Expression, Duke Human Vaccine Institute

Sukrit Srivastava, Ph.D

Research Group Leader, Infection Biology Group, Indian Foundation for Fundamental Research

Michael Schotsaert, Ph.D

Assistant Professor, Microbiology, Icahn School of Medicine at Mount Sinai

Presentation Title

David Weinreich, M.D., MBA

Executive Vice President, Regeneron Pharmaceuticals, Inc, Head of Global Clinical Development, Co-Head of Global Development

In-Jeong Kim, Ph.D.

Principal Investigator, Viral Immunity Division, Trudeau Institute Inc

Robert O. Dillman, M.D.

Chief Medical Officer, AIVITA Biomedical, Inc

Charlotte Thalin, Ph.D.

Karolinska Institutet

Jim Koopman, M.D., MPH

Developing Theory that Serves the Public Health

David E. Wentworth, Ph.D.

Director, WHO Collaborating Center for Surveillance, Epidemiology and Control of Influenza, Branch Chief, Virology Surveillance and Diagnosis, CDC

Jerald C. Sadoff, Ph.D.

Senior Advisor, Janssen

Bert Jacobs, Ph.D.

Professor, School of Life Sciences, Member, Biodesign Center for Immunotherapy, Vaccines and Virotherapy, Arizona State University

Steven P. Fling, Ph.D.

Sr. Staff Scientist, Fred Hutch, CITN Lab Director

Nicolas Çuburu, Ph.D.

Staff Scientist, Laboratory of Cellular Oncology, Center for Cancer Research, NCI

Baochun Zhang, MB, Ph.D.

Assistant Professor, Harvard Medical School, Division of Hematologic Neoplasia, Department of Medical Oncology, Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute

Joseph A. Vetro, Ph.D.

Associate Professor, Department of Pharmaceutical Sciences, University of Nebraska Medical Center

Presentation Title

Leonidas Stamatatos, Ph.D.

Professor, Fred Hutchinson Cancer Research Center, Vaccine and Infectious Disease Division

Presentation Title

Pragya D Yadav, M.Sc., Ph.D

Scientist 'E' and Group Leader, Maximum Containment Laboratory, Indian Council of Medical Research-National Institute of Virology

Allen (Chia En) Lien, M.D., DrPH

VP, International and Governmental Affairs, MEDIGEN VACCINE BIOLOGICS CORP

Stephen Albert Johnston, Ph.D

Co-Founder, Calviri, Inc

Presentation Title

Vjollca Konjufca, Ph.D

Associate Professor, Southern Illinois University

Daniel Kulp, Ph.D

Associate Professor, Vaccine & Immunotherapy Center, The Wistar Institute

Tomáš Hanke, Ph.D

The Jenner Institute, Nuffield Department of Medicine, University of Oxford

Jiang Zhu, Ph.D

Associate Professor, Integrative Structural and Computational Biology, Immunology and Microbiology, The Scripps Research Institute

Alexandre Le Vert, Ph.D

Chairman, CEO and Cofounder, OSIVAX

Barbara A. Jones, Ph.D

IBM Research Almaden

Presentation Title

Masfique Mehedi, Ph.D

Assistant Professor, Dept. of Biomedical Sciences, School of Medicine & Health Sciences,Univer sity of North Dakota

Shahin Gharakhanian, MD, DPH

Pharmaceutical Medicine, Infectious Diseases, Shahin Gharakhanian MD Consulting LLC, CIC: Cambridge Innovation Center

Geoffrey Lynn, Ph.D

SVP, Synthetic Immunotherapies, Vaccitech

Mark Connors, M.D

Chief, HIV-Specific Immunity Section, NIAID/LIR

Denise L Faustman, M.D., Ph.D.

Director of Immunobiology, Massachusetts General Hospital, Associate Professor of Medicine, Harvard Medical School

Presentation Title

Wei Shen, Ph.D.

Immunomic Therapeutics, Inc.

Presentation Title

Ashima Shukla, Ph.D.

CSO and co-founder, Styx Biotechnologies Inc

Dahlene Fusco, MD, PhD

Assistant Professor of Medicine, Tulane University School of Medicine

Martha Alexander-Miller, MD, PhD

Professor and Chair, Dept. of Microbiology and Immunology, Director Center for Vaccines at the Extremes of Aging, Wake Forest School of Medicine

Peter Palese, PhD

Horace W. Goldsmith Professor and Chair, Department of Microbiology, Professor, Department of Medicine, Icahn School of Medicine at Mount Sinai

Presentation Title

Robert Carnahan, PhD

Associate Director, Vanderbilt Vaccine Center

Petro Terblanche, PhD

Managing Director: Afrigen Biologics

Seshadri S. Vasan, DPhil(Oxon)

Honorary Professor of Health Sciences, University of York, UK

Presentation Title

Thomas Tillett, PhD

CEO, MBF Therapeutics

Presentation Title
thumb-image

Li Shi, PhD

Yidao Biotechnology CO., Ltd

Presentation Title
thumb-image

Tomas Hanke, PhD

The Jenner Institute, Nuffield Department of Medicine, University of Oxford

Presentation Title

M. Javad Aman, PhD

President and CSO, Integrated Biotherapeutics Inc.,

Presentation Title

Paul LaBarre, MS, MBA

Vice President of Global Business Development, PharmaJet

Biography

Stéphane Pillet, PhD

Clinical Immunology Manager, Scientific and Medical Affairs, Medicago

Presentation Title

Raiees Andrabi, PhD

Institute Investigator, Department of Immunology and Microbiology, The Scripps Research Institute

Presentation Title
thumb-image

Philip R Krause

Former FDA Deputy Director, Office of Vaccines Research and Review, Consultant, World Health Organization

Presentation Title

Andrew M. Lewis JR., MD

Office of Vaccines Research and Review, Division of Viral Products, Laboratory of DNA Viruses

Presentation Title

Pravin T.P. Kaumaya, PhD

Professor Ob/Gyn, Molecular and Cellular Biochemistry, Director Div. of VACCINE DEVELOPMENT/ Peptide & Protein Engineering Laboratory

Presentation Title

Steve Steinhubl, MD

Chief Medical Officer, physIQ

Presentation Title

Yang Xu, PhD

Director and full professor, Shanghai University of Medicine and Health Sciences

Presentation Title

Shelly J. Krebs, PhD

Chief, B cell Biology I HJF, In support of the US Military HIV Research Program (MHRP), and the Emerging Infectious Disease Branch (EIDB), Walter Reed Army Institute of Research (WRAIR)

Presentation Title

Theodore (Ted) Schenkelberg, MBA, MPH

Senior Vice President and Chief Strategy Officer, Human Vaccines Project

Jonathan Lovell, PhD

Associate Professor of Biomedical Engineering, University at Buffalo

Presentation Title

Marco Pravetoni, PhD

Professor of Psychiatry and Behavioral Sciences, University of Washington School of Medicine; Director, Center for Medication Development for Substance Use Disorders and Overdose

Presentation Title

Catarina Hioe, PhD

Professor, Medicine, Infectious Diseases, Icahn School of Medicine at Mount Sinai

Presentation Title

Savannah Knell

Senior Director of Strategic Partnerships, The Public Good Projects (PGP)

Joe Smyser, PhD

CEO, PGP (The Public Good Projects)

thumb-image

David C. Montefiori, PhD

Professor, Department of Surgery, Director, Laboratory for HIV and COVID-19 Vaccine Research & Development, Department of Surgery, Duke University Medical Center

Presentation Title

Nash Rochman

IRTA Fellow, National Institute of Health

Rama Rao Amara, PhD

Charles Howard Candler Professor, Department of Microbiology and Immunology, Associate Director, Vaccine Development, Emory Vaccine Center, Co-Director, Developmental Core, Emory CFAR, Yerkes National Primate Research Center, Emory University

Lisa M. Dunkle, MD

Vice President, Clinical Development, Global Medical Lead, Coronavirus Vaccine, Novavax, Inc.

David J. Dowling, PhD

Principal Investigator, Adjuvant Discovery and Development Lab, Precision Vaccines Program, Division of Infectious Diseases, Boston Children's Hospital, & Instructor of Pediatrics, Harvard Medical School. Harvard Institutes of Medicine

Presentation Title

Samuel Fosu Gyasi, PhD

Associate Professor: Microbiology and Global Health, Head; Centre for Research in Applied Biology (CeRAB), University of Energy & Natural Resources-Ghana

Presentation Title
thumb-image

Leonora Hana Lleshi, MD

Allergist-immunologist, KOSOVO

Waranyoo Phoolcharoen

Associate Professor, Faculty of Pharmaceutical Sciences, Chulalongkorn University, CTO and Co-Founder, Baiya Phytopharm Co., Ltd

Presentation Title

SIDDAPPA N. BYRAREDDY, PhD

Professor & Vice Chair of Research, Department of Pharmacology & Experimental Neuroscience, University of Nebraska Medical Center

Presentation Title
thumb-image

Patrick Ahl, PhD

Principal Scientist, Merck Vaccine R&D

Sidi Chen

Yale School of Medicine

Presentation Title

Nektaria Karavas

Director of Business Development, Prescription Division, Aptar Pharma

Julie D. Suman, RPh, PhD

Vice President of Scientific Affairs, Aptar Pharma

Maria Gomes-Solecki, RPh, PhD

Professor of Microbiology, Immunology and Biochemistry at the University of Tennessee Health Science Center

Presentation Title

Phanramphoei (Jibby) Frantz

National Center for Genetic Engineering and Biotechnology (BIOTEC) & Institut Pasteur


About Organizer

Scientia Meetings understand the importance of networking and collaboration. Conferences are not just about discussion, but to sharing knowledge and research work, new ideas, and a lot of opportunities. We are launching events in the country to create real networking with scientists and researchers from research institutes, companies, laboratories, and government agencies. We aim to have our events with only a moderate number of invited guests/delegates attending related to discipline and to create a platform to have conversations leading to opportunities according to their respective needs. Our aim is to provide a platform for research scholars, scientific leaders, decision-makers to come together and share their research findings with the other scientific professionals which helps to improve the sharing of knowledge and easy access to scientific information.

We provide a unique opportunity to share your innovative ideas, evaluate your research works, and promote collaborative work through its networking sessions for a brighter future.